We are live on ! Find out more
LEGN icon

Legend Biotech

139 hedge funds and large institutions have $2.33B invested in Legend Biotech in 2021 Q4 according to their latest regulatory filings, with 66 funds opening new positions, 44 increasing their positions, 23 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

371% more first-time investments, than exits

New positions opened: 66 | Existing positions closed: 14

91% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 23

58% more funds holding

Funds holding: 88139 (+51)

18% more capital invested

Capital invested by funds: $1.97B → $2.33B (+$357M)

2.95% more ownership

Funds ownership: 13.48%16.43% (+2.9%)

0% more funds holding in top 10

Funds holding in top 10: 66 (0)

53% less call options, than puts

Call options by funds: $2.89M | Put options by funds: $6.1M

Holders
139
Holders Change
+51
Holders Change %
+57.95%
% of All Funds
2.14%
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.09%
New
66
Increased
44
Reduced
23
Closed
14
Calls
$2.89M
Puts
$6.1M
Net Calls
-$3.21M
Net Calls Change
-$3.6M
Name Holding Trade Value Shares
Change
Change in
Stake
Vontobel Holding
76
Vontobel Holding
Switzerland
$1.42M -$289K -5,704 -17%
MIM
77
Monashee Investment Management
Massachusetts
$1.4M +$1.52M +30,000 New
PPA
78
Parametric Portfolio Associates
Washington
$1.32M +$1.43M +28,241 New
Jane Street
79
Jane Street
New York
$1.26M +$810K +15,964 +143%
VIA
80
Vident Investment Advisory
Georgia
$1.26M -$719K -14,169 -34%
KBC Group
81
KBC Group
Belgium
$1.2M +$289K +5,702 +28%
Korea Investment Corp
82
Korea Investment Corp
South Korea
$1.14M +$1.24M +24,500 New
SEI Investments
83
SEI Investments
Pennsylvania
$1.12M +$501K +9,872 +70%
Mackenzie Financial
84
Mackenzie Financial
Ontario, Canada
$1.1M +$1.19M +23,508 New
Citadel Advisors
85
Citadel Advisors
Florida
$1.08M -$7.14M -140,745 -86%
KFA
86
Krane Funds Advisors
New York
$951K +$1.02M +20,130 +7,215%
BCIM
87
British Columbia Investment Management
British Columbia, Canada
$881K +$959K +18,900 New
Asset Management One
88
Asset Management One
Japan
$861K +$925K +18,230 New
Squarepoint
89
Squarepoint
New York
$815K +$887K +17,476 New
Aviva
90
Aviva
United Kingdom
$774K +$842K +16,600 New
Public Sector Pension Investment Board (PSP Investments)
91
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$763K +$830K +16,369 New
Zurich Cantonal Bank
92
Zurich Cantonal Bank
Switzerland
$716K +$540K +10,641 +225%
Mitsubishi UFJ Asset Management
93
Mitsubishi UFJ Asset Management
Japan
$701K +$307K +6,048 +71%
AIMCA
94
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$649K +$707K +13,933 New
LP
95
LMR Partners
United Kingdom
$489K +$533K +10,501 New
CF
96
CNA Financial
Illinois
$482K -$41.6K -820 -7%
Mitsubishi UFJ Trust & Banking
97
Mitsubishi UFJ Trust & Banking
Japan
$482K +$525K +10,344 New
RC
98
Renaissance Capital
Connecticut
$443K +$482K +9,495 New
NFGH
99
Nan Fung Group Holdings
Hong Kong
$435K +$474K +9,340 New
SFI
100
Susquehanna Fundamental Investments
Pennsylvania
$431K -$21.3K -420 -4%

LEGN Hedge Fund Activity: Q4 2021 in Review

139 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Legend Biotech (LEGN) for Q4 2021, worth a combined $2.33B — up 18% from $1.97B a quarter earlier.

Buyers outnumbered sellers: 66 funds opened new LEGN positions and 14 closed out — a net gain of 52 holders — while 44 added to existing stakes and 23 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $85.4M. The largest seller was Matthews International Capital Management, cutting an estimated $17.8M.

  • 139 institutional investors held Legend Biotech (LEGN) as of Q4 2021, up from 88 in Q3 2021.
  • Funds reported $2.33B of Legend Biotech stock for Q4 2021, up 18% quarter-over-quarter.
  • 66 funds opened new Legend Biotech positions in Q4 2021 and 14 closed out, a net change of +52 holders.
  • The largest Legend Biotech buyer in Q4 2021 was Wellington Management Group, an estimated $85.4M added.
  • The largest Legend Biotech seller in Q4 2021 was Matthews International Capital Management, an estimated $17.8M sold.

Based on aggregated 13F filings for Q4 2021.